Two Sigma Advisers’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Two Sigma Advisers’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-104,800	Closed	-$14.3M	–	2686
2020 Q3	$14.3M	Sell	104,800 -106,800	-50%	-$11.4M	0.04%	420
2020 Q2	$20.4M	Buy	211,600 +8,200	+4%	+$684K	0.06%	318
2020 Q1	$9.54M	Buy	+203,400	New	+$13M	0.04%	495
2019 Q2	–	Sell	-4,800	Closed	-$250K	–	2502
2019 Q1	$250K	Buy	+4,800	New	+$221K	﹤0.01%	2050

Two Sigma Advisers's MYOK Position: Q4 2020 in Review

Two Sigma Advisers sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 104,800 shares — an estimated $14.3M sold.

Two Sigma Advisers first reported a position in MYOK in Q1 2019 and held it in 4 quarters. The position peaked at $20.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Two Sigma Advisers reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Two Sigma Advisers sold 104,800 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $14.3M.
Two Sigma Advisers first reported a position in MyoKardia, Inc. Common Stock in Q1 2019 and held it in 4 quarters.
Two Sigma Advisers's MyoKardia, Inc. Common Stock position peaked at $20.4M in Q2 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Two Sigma Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.